Clinical trial

Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients

NCT01910441

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE4

Study timeline

Study start (unknown)2013-07-01Date precision: month

Registry last updated2015-10-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

VildagliptinDRUG

GlimepirideDRUG · verified · RxNorm: glimepiride

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01910441 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.